The Parenteral Drug Association (PDA) has recently published Technical Report No. 82 (TR82) on the topic of Low Endotoxin Recovery (LER), providing both consensus to the science and data behind the analytical issue, as well as to analytical and mitigation strategies.

In this webinar, Kevin Williams and Dr. Christian Faderl from bioMérieux, explain the important implications of TR82 as well as presenting the ENDO-RS^® sample preparation technology for demasking endotoxin in affected biologics, as described in Case Study 7 of TR82.